Breaking Finance News

ValuEngine upgraded Check Cap Ltd (NASDAQ:CHEK) to Sell in a report released today.

Just yesterday Check Cap Ltd (NASDAQ:CHEK) traded -0.70% lower at $1.98. Check Cap Ltd’s 50-day average is $1.82 and its 200-day moving average is $1.82. The last closing price is up -8.11% from the 200-day moving average, compared to the S&P 500 which has increased 0.03% over the same time period. 20,783 shares of CHEK traded hands, down from an average trading volume of 46,400

ValuEngine has upgraded Check Cap Ltd (NASDAQ:CHEK) to Sell in a report released on 6/02/2017.

Previously on 6/1/2017, Zacks Investment Research released a statement about Check Cap Ltd (NASDAQ:CHEK) increased the target price from $0.00 to $2.25. At the time, this indicated a possible upside of 0.14%.

Recent Performance Chart

Check Cap Ltd (NASDAQ:CHEK)

Check Cap Ltd has 52 week low of $1.66 and a 52 week high of $2.95 and has a market capitalization of $0.

Also covering Check Cap Ltd's target, a total of 2 equity analysts have released a ratings update on CHEK. The one year price target is $8.50 with zero brokerages rating the company a strong buy, 0 firms rating the stock a buy, 0 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 firms rating the stock a sell.

About Check Cap Ltd (NASDAQ:CHEK)

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company's system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient's back, and a personal computer (PC)-based work station for data reconstruction and image processing. The Company's scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. Its scanning capsule employs low-dose X-rays, which allow the system to image the interior lining of the colon even when surrounded by intestinal content. Its capsule transmits information to a receiving device worn on the patient's body that stores the information for off-line analysis.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.